These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37172500)

  • 1. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
    Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
    Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of the Negative Symptom Inventory-Psychosis Risk.
    Strauss GP; Walker EF; Pelletier-Baldelli A; Carter NT; Ellman LM; Schiffman J; Luther L; James SH; Berglund AM; Gupta T; Ristanovic I; Mittal VA
    Schizophr Bull; 2023 Sep; 49(5):1205-1216. PubMed ID: 37186040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.
    Park SG; Llerena K; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
    Schizophr Res; 2012 Mar; 135(1-3):139-43. PubMed ID: 22265640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.
    Strauss GP; Gold JM
    Schizophr Bull; 2016 Nov; 42(6):1384-1394. PubMed ID: 27174556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and extension of the Motivation and Pleasure Scale-Self Report (MAP-SR) across the schizophrenia spectrum in the Chinese context.
    Wang LL; Ma EPY; Lui SSY; Cheung EFC; Cheng KS; Chan RCK
    Asian J Psychiatr; 2020 Mar; 49():101971. PubMed ID: 32065963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.
    Llerena K; Park SG; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
    Compr Psychiatry; 2013 Jul; 54(5):568-74. PubMed ID: 23351831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Forbes C; Blanchard JJ; Bennett M; Horan WP; Kring A; Gur R
    Schizophr Res; 2010 Dec; 124(1-3):36-42. PubMed ID: 20869848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.
    Strauss GP; Vertinski M; Vogel SJ; Ringdahl EN; Allen DN
    Schizophr Res; 2016 Feb; 170(2-3):285-9. PubMed ID: 26742510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
    Engel M; Lincoln TM
    Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.
    Strauss GP; Macdonald KI; Ruiz I; Raugh IM; Bartolomeo LA; James SH
    Eur Arch Psychiatry Clin Neurosci; 2022 Feb; 272(1):17-27. PubMed ID: 33881621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geolocation as a Digital Phenotyping Measure of Negative Symptoms and Functional Outcome.
    Raugh IM; James SH; Gonzalez CM; Chapman HC; Cohen AS; Kirkpatrick B; Strauss GP
    Schizophr Bull; 2020 Dec; 46(6):1596-1607. PubMed ID: 32851401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental factors contributing to negative symptoms in youth at clinical high risk for psychosis and outpatients with schizophrenia.
    Strauss GP
    Soc Psychiatry Psychiatr Epidemiol; 2024 Jul; 59(7):1167-1175. PubMed ID: 37624464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains.
    Chang WC; Strauss GP; Ahmed AO; Wong SCY; Chan JKN; Lee EHM; Chan SKW; Hui CLM; James SH; Chapman HC; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):386-394. PubMed ID: 32909606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder.
    Strauss GP; Esfahlani FZ; Kirkpatrick B; Allen DN; Gold JM; Visser KF; Sayama H
    Schizophr Bull; 2019 Oct; 45(6):1319-1330. PubMed ID: 30649527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Horan WP; Kring AM; Gur RE; Reise SP; Blanchard JJ
    Schizophr Res; 2011 Nov; 132(2-3):140-5. PubMed ID: 21798716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.
    Bischof M; Obermann C; Hartmann MN; Hager OM; Kirschner M; Kluge A; Strauss GP; Kaiser S
    BMC Psychiatry; 2016 Nov; 16(1):415. PubMed ID: 27876020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of psychotic experiences in adolescence using the specific psychotic experiences questionnaire: findings from a study of 5000 16-year-old twins.
    Ronald A; Sieradzka D; Cardno AG; Haworth CM; McGuire P; Freeman D
    Schizophr Bull; 2014 Jul; 40(4):868-77. PubMed ID: 24062593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
    García-Álvarez L; Martínez-Cao C; Bobes-Bascarán T; Portilla A; Courtet P; de la Fuente-Tomás L; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):14-21. PubMed ID: 35256068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia.
    Ahmed AO; Kirkpatrick B; Galderisi S; Mucci A; Rossi A; Bertolino A; Rocca P; Maj M; Kaiser S; Bischof M; Hartmann-Riemer MN; Kirschner M; Schneider K; Garcia-Portilla MP; Mane A; Bernardo M; Fernandez-Egea E; Jiefeng C; Jing Y; Shuping T; Gold JM; Allen DN; Strauss GP
    Schizophr Bull; 2019 Mar; 45(2):305-314. PubMed ID: 29912473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The brief negative symptom scale in translation: A review of psychometric properties and beyond.
    Tatsumi K; Kirkpatrick B; Strauss GP; Opler M
    Eur Neuropsychopharmacol; 2020 Apr; 33():36-44. PubMed ID: 32081498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.